Ovarian Suppression的临床试验
总计4870个结果
-
Tam Anh TP. Ho Chi Minh General HospitalAbbott招聘中
-
Shandong UniversityThe Second Hospital of Hebei Medical University; RenJi Hospital尚未招聘
-
Ferring Pharmaceuticals完全的受控卵巢刺激英国, 丹麦, 比利时, 捷克语, 西班牙
-
Ferring Pharmaceuticals完全的受控卵巢刺激澳大利亚, 奥地利, 比利时, 加拿大, 德国, 意大利, 荷兰, 波兰, 西班牙, 英国
-
Organon and Co完全的
-
Shaanxi Hospital of Traditional Chinese MedicineNorthwest Women's and Children's Hospital, Xi'an, Shaanxi未知
-
GeneScience Pharmaceuticals Co., Ltd.Peking University People's Hospital; Peking University Third Hospital未知
-
Peking University People's HospitalBeijing Weixiao Biotechnology Development Limited招聘中
-
National Cancer Institute (NCI)NRG Oncology完全的恶性卵巢上皮性肿瘤 | 卵巢两性母细胞瘤 | 卵巢支持间质细胞瘤 | 卵巢性索肿瘤伴环状小管 | 卵巢类固醇细胞瘤 | 卵巢颗粒细胞瘤 | 卵巢性索间质瘤 | 混合或未分类细胞类型的卵巢性索间质瘤美国
-
Grupo Español de Investigación en Cáncer de OvarioRoche Pharma AG终止
-
Japanese Gynecologic Oncology GroupKorean Gynecologic Oncology Group招聘中
-
Women's Hospital School Of Medicine Zhejiang University主动,不招人
-
Universitaire Ziekenhuizen KU LeuvenAstraZeneca主动,不招人
-
Chang Gung Memorial HospitalHoffmann-La Roche; Asian Gynecologic Oncology Group; Taiwanese Gynecolgic Oncology Group完全的
-
Sunesis Pharmaceuticals完全的
-
Gynecologic Oncology AssociatesUniversity of North Carolina, Chapel Hill未知
-
Vanderbilt UniversityNational Cancer Institute (NCI); Celgene Corporation完全的
-
AbbVie (prior sponsor, Abbott)Biogen完全的